Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Prevacid generic?

See the DrugPatentWatch profile for Prevacid

Prevacid is the brand name for the proton‑pump inhibitor (PPI) omeprazole.
The generic drug is simply omeprazole and is sold in most pharmacies under that name (often just “omeprazole” on the bottle).


What It Does

  • Reduces stomach acid by blocking the H⁺/K⁺‑ATPase “proton pump” in parietal cells.
  • Treats conditions such as:
    • Gastro‑oesophageal reflux disease (GERD)
    • Peptic ulcer disease (often used with antibiotics for H. pylori)
    • Zollinger–Ellison syndrome (gastric acid‑secreting tumors)
    • Prevention of NSAID‑induced ulcers

Dosage Forms (Generic)

Form Typical Strengths Typical Use
Tablet (orodispersible) 20 mg, 40 mg Most common for GERD and ulcers
Capsule 20 mg, 40 mg Alternative for those who prefer capsules
Oral suspension 10 mg/5 mL For children or patients who can’t swallow pills
Injectable (IV) 10 mg, 20 mg Hospital use for severe ulcer bleeding or pre‑operative acid suppression

All doses are usually taken once daily, about 30–60 minutes before a meal.

How It Differs from the Brand (if at all)

  • Active ingredient: identical (omeprazole)
  • Excipients: may vary, but generally not clinically significant
  • Cost: generics are typically 10‑20 % of the brand price
  • Insurance coverage: many plans cover the generic first; you may be required to try the generic before being approved for the brand

Common Side Effects

  • Headache
  • Nausea, abdominal pain, diarrhea or constipation
  • Flatulence
  • Rare: dizziness, rash, or allergic reactions

Long‑term use (≥4 weeks) can be associated with:

  • Vitamin B12 deficiency
  • Low magnesium
  • Increased risk of bone fractures (especially with ≥12 months of therapy)
  • Possible increased susceptibility to certain infections (e.g., C. difficile, pneumonia)

Precautions & Interactions

Precaution Why?
Pregnancy Generally considered safe (Category B), but use only if needed
Breastfeeding Low transfer; usually considered safe
Kidney impairment Dose adjustments may be needed
Liver impairment Standard doses are usually fine; monitor for hepatotoxicity
Drug interactions Omeprazole can reduce absorption of drugs that need an acidic environment (e.g., ketoconazole, atazanavir); it can also increase plasma levels of drugs metabolized by CYP2C19 and CYP3A4 (e.g., clopidogrel, diazepam).

When to Talk to Your Doctor

  • Persistent heartburn or acid reflux after 4‑8 weeks of therapy
  • Signs of ulcer bleeding (black/tarry stools, vomiting blood)
  • If you’re on chronic NSAIDs and have risk factors for ulcers
  • If you develop any severe or persistent side effects

Quick Takeaway

Prevacid’s generic, omeprazole, works the same way, is available in multiple strengths, and is usually much cheaper.
If you’re considering switching or starting therapy, it’s a good idea to check with your pharmacist or prescriber to confirm the right dose and ensure it’s appropriate for your medical history.



Other Questions About Prevacid :

What is the difference between prevacid and nexium? Difference between prevacid and prilosec? Prevacid generic name? Generic for prevacid? Prevacid ingredients? Prevacid vs prilosec? Prevacid cost?

AI-Drug Label Prescribing Information Alignment Report

35
35%
Grade D

Poor

Not Aligned

Patient Risk: Low

Summary

Only a minority of claims are supported by the provided FDA label excerpts (11 DESCRIPTION and 3 DOSAGE FORMS AND STRENGTHS). Multiple claims are unsubstantiated by the provided labeling and several include general switching/substitution guidance and third-party website utility statements not found in the supplied sections.


Category Scores

Dosage
35
Poor

Accurate Statements

Prevacid is the brand name for lansoprazole.
Supported by 11 DESCRIPTION: “active ingredient in PREVACID Delayed-Release Capsules… is lansoprazole.”
Lansoprazole delayed-release capsules are the same active ingredient class as Prevacid.
Supported by 11 DESCRIPTION: PREVACID Delayed-Release Capsules contain lansoprazole as the active ingredient.

Unsupported Statements

Multiple generic lansoprazole products are available in the U.S.
Not stated in the provided label sections (11 DESCRIPTION, 3 DOSAGE FORMS AND STRENGTHS).
Most generic substitutions are for lansoprazole delayed-release capsules.
Not stated in the provided label sections.
Generic lansoprazole delayed-release capsules are marketed by various manufacturers with different strengths and package sizes.
Not stated in the provided label sections.
Availability of generic lansoprazole can vary by dose.
Not stated in the provided label sections.
Availability of generic lansoprazole can vary by whether the product is a capsule or another formulation.
Not stated in the provided label sections.
In general, switching from Prevacid to a generic requires matching the same active ingredient (lansoprazole).
The label excerpt supports that Prevacid contains lansoprazole, but it does not provide general switching/substitution requirements for generics.
In general, switching from Prevacid to a generic requires matching the same release type.
Not stated in the provided label sections.
If a prescription is for a delayed-release formulation, the generic should also be delayed-release.
Not stated in the provided label sections; no substitution guidance is provided.
DrugPatentWatch.com tracks relevant patent information and potential generic-entry timing for branded drugs and their active ingredients.
Not stated in the provided FDA label sections; this is an external third-party claim.
DrugPatentWatch.com can help look up lansoprazole-related branded versus generic/patent context.
Not stated in the provided FDA label sections; external third-party claim.
DrugPatentWatch.com can help confirm whether a generic should be available for a specific marketed product strength/formulation.
Not stated in the provided FDA label sections; external third-party claim.

Contradictions


Important Omissions

No evaluation of contraindications/boxed warnings/warnings & precautions/drug interactions/use in specific populations/adverse reactions/monitoring/dosing & administration instructions was possible because those label sections were not provided in the input.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The only label-supported content concerns the active ingredient. However, several unlabel-supported statements provide generic-switching/substitution and third-party website utility guidance, which could indirectly influence medication selection despite not being grounded in the provided FDA label excerpts.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Not Aligned

Primary Issue
Most claims are not supported by the provided FDA label excerpts and include speculative generalizations (generic switching/release-type matching) and non-label third-party website assertions.

Suggested Improvement
Limit statements to what is explicitly supported by the provided label sections (e.g., that Prevacid products contain lansoprazole and are supplied as delayed-release capsules/tablets). Remove or reframe claims about generic availability, switching requirements, release-type matching, and third-party site usefulness unless corresponding FDA label sections are provided.

Drug Brand Mention Assessment

Branding Score
69
Visibility
69
Mentioned
Ranking
#1
Sentiment
60
Recommendation Status
strong alternative
Brand Perception
Best Known For

brand name for lansoprazole


Core Claims
  • Prevacid is the brand name for lansoprazole
  • multiple generic lansoprazole products are available in the U.S.
  • Most generic substitutions are for lansoprazole delayed-release capsules
Differentiators
  • Prevacid corresponds to the active ingredient lansoprazole
  • generic substitution depends on matching the same release type (e.g., delayed-release)

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 34%
50 #4 No